Tag · 14 articles
preclinical
Research-use-only roundups tagged preclinical.
AOD-9604: Research Roundup
An hGH fragment analog with lipolytic research interest. What preclinical literature reports — and where the evidence gaps are.
B7-33: Research Roundup
A single-chain relaxin-2 B-chain analog and biased RXFP1 agonist. Anti-fibrotic rodent literature, signaling selectivity, and synthesis identity requirements.
BPC-157: Research Roundup
A pentadecapeptide studied extensively in rodent models. What the preclinical literature reports — and what remains unestablished in humans.
Dihexa: Research Roundup
An HGF-mimetic oligopeptide studied for synaptogenesis in rodent cognition models. What the preclinical record reports — and what remains unestablished in humans.
GHRP-2: Research Roundup
A classic growth hormone releasing peptide with decades of GH-axis research. Literature summary, limitations, and material evaluation.
GHRP-6: Research Roundup
A first-generation GHRP widely cited in secretagogue research. GH-axis literature, noted appetite effects in models, and quality checks.
Hexarelin: Research Roundup
A potent hexapeptide ghrelin mimetic with GH-axis and cardioprotective research angles in animal models. Evidence and limitations.
IGF-1 LR3: Research Roundup
A long-acting IGF-1 analog engineered for reduced IGFBP binding. GroPep-era pharmacology, preclinical anabolic literature, and strict identity requirements for an 83-mer.
Ipamorelin: Research Roundup
A selective growth hormone secretagogue studied in GH-axis research. Ghrelin receptor pharmacology, literature, and material quality.
P21: Research Roundup
A CNTF-derived synthetic peptide studied for neurogenesis in brain-injury models. Preclinical literature, naming pitfalls, and material verification for research supply.
PEG-MGF: Research Roundup
Pegylated synthetic MGF with extended half-life — a non-endogenous construct studied in muscle repair models. Preclinical-only evidence and strict identity requirements.
PNC-27: Research Roundup
A synthetic p53-derived peptide studied in preclinical oncology models. What selective cytotoxicity literature reports — and where human evidence ends.
Semaglutide: Research Roundup
A GLP-1 receptor agonist with extensive published literature. What preclinical and clinical research reports — within an RUO frame.
TB-500 (Thymosin Beta-4 Fragment): Research Roundup
TB-500 is associated with thymosin beta-4 biology. A look at the actin-binding research context and the gaps in human evidence.